Differences between familial and sporadic cases of vitiligo
Background Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history. Objective The aim of our study was to describe differences between familial and sporadic cases of vitiligo. Methods A total of 186 adult vitiligo patients were examined, in 173 of whom t...
Gespeichert in:
Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2012-07, Vol.26 (7), p.915-918 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 918 |
---|---|
container_issue | 7 |
container_start_page | 915 |
container_title | Journal of the European Academy of Dermatology and Venereology |
container_volume | 26 |
creator | Karelson, M. Silm, H. Salum, T. Kõks, S. Kingo, K. |
description | Background Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history.
Objective The aim of our study was to describe differences between familial and sporadic cases of vitiligo.
Methods A total of 186 adult vitiligo patients were examined, in 173 of whom the level of thyroid peroxidase antibodies, gastric parietal cell antibodies (PCA), antinuclear antibodies (ANA), anti‐adrenal cortex antibodies and rheumatoid factor in blood was measured. All patients were divided in two groups: the cases with positive family history of vitiligo (51) and the sporadic cases (135).
Results The risk of onset of the disease up to 20 years of age was higher in the familial group (P = 0.008). Patients in familial group showed more widespread depigmentation compared with sporadic cases [body surface area (BSA) over 10%: P = 0.004; BSA over 50%: P = 0.001]. In familial group, patients had darker skin phototype (P = 0.045) and the disease had started more often as a vulgar vitiligo (P = 0.008). In sporadic vitiligo group, female gender was a risk factor for more widespread depigmentation (BSA over 10%, P = 0.001). Extensive depigmentation was associated with reported triggering factors and mucosal involvement in both groups and with leukotrichia only in familial group. Widespread depigmentation related to the risk of presence of autoantibodies (P = 0.03) in sporadic cases of vitiligo (especially of PCA: P = 0.04 and ANA: P = 0.0002).
Conclusions In this study, we demonstrated first time that patients with familial vitiligo have a higher risk for vulgar type at the beginning of the disease and female gender increases the risk for more extensive depigmentation in sporadic cases. |
doi_str_mv | 10.1111/j.1468-3083.2011.04131.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1022259498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1022259498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4071-aa0da2e8a98e6d016569a193e5d24b3c24f4dd4343bf6fa9abdb702aac0937953</originalsourceid><addsrcrecordid>eNqNkMlOwzAQQC0EomX5BZQjlwRvWSzEAbEjKBJiu1mTeIxc0qbELbR_j0NLz_hiS_PeWHqERIwmLJyjYcJkVsSCFiLhlLGESiZYMt8g_fVgk_Sp4lmsVKp6ZMf7IaUBTYtt0uMs40Lxok-Oz5212OK4Qh-VOP1GHEcWRq52UEcwNpGfNC0YV0UV-MA0Nvpy0zB-b_bIloXa4_7q3iXPlxdPZ9fx3cPVzdnpXVxJmrMYgBrgWIAqMDOUZWmmgCmBqeGyFBWXVhojhRSlzSwoKE2ZUw5QUSVylYpdcrjcO2mbzxn6qR45X2FdwxibmdeMcs5TJVUR0GKJVm3jfYtWT1o3gnYRIN2l00PdFdJdId2l07_p9DyoB6tfZuUIzVr8axWAkyXw7Wpc_Huxvj1_6V7Bj5e-81Ocr31oP3SWizzVr4MrfU3vc_nGBvpR_ADXFIsx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1022259498</pqid></control><display><type>article</type><title>Differences between familial and sporadic cases of vitiligo</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Karelson, M. ; Silm, H. ; Salum, T. ; Kõks, S. ; Kingo, K.</creator><creatorcontrib>Karelson, M. ; Silm, H. ; Salum, T. ; Kõks, S. ; Kingo, K.</creatorcontrib><description>Background Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history.
Objective The aim of our study was to describe differences between familial and sporadic cases of vitiligo.
Methods A total of 186 adult vitiligo patients were examined, in 173 of whom the level of thyroid peroxidase antibodies, gastric parietal cell antibodies (PCA), antinuclear antibodies (ANA), anti‐adrenal cortex antibodies and rheumatoid factor in blood was measured. All patients were divided in two groups: the cases with positive family history of vitiligo (51) and the sporadic cases (135).
Results The risk of onset of the disease up to 20 years of age was higher in the familial group (P = 0.008). Patients in familial group showed more widespread depigmentation compared with sporadic cases [body surface area (BSA) over 10%: P = 0.004; BSA over 50%: P = 0.001]. In familial group, patients had darker skin phototype (P = 0.045) and the disease had started more often as a vulgar vitiligo (P = 0.008). In sporadic vitiligo group, female gender was a risk factor for more widespread depigmentation (BSA over 10%, P = 0.001). Extensive depigmentation was associated with reported triggering factors and mucosal involvement in both groups and with leukotrichia only in familial group. Widespread depigmentation related to the risk of presence of autoantibodies (P = 0.03) in sporadic cases of vitiligo (especially of PCA: P = 0.04 and ANA: P = 0.0002).
Conclusions In this study, we demonstrated first time that patients with familial vitiligo have a higher risk for vulgar type at the beginning of the disease and female gender increases the risk for more extensive depigmentation in sporadic cases.</description><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/j.1468-3083.2011.04131.x</identifier><identifier>PMID: 21623928</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Autoantibodies - analysis ; Autoantibodies - immunology ; Child ; Child, Preschool ; Humans ; Middle Aged ; Vitiligo - diagnosis ; Vitiligo - genetics ; Vitiligo - immunology ; Young Adult</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2012-07, Vol.26 (7), p.915-918</ispartof><rights>2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology</rights><rights>2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4071-aa0da2e8a98e6d016569a193e5d24b3c24f4dd4343bf6fa9abdb702aac0937953</citedby><cites>FETCH-LOGICAL-c4071-aa0da2e8a98e6d016569a193e5d24b3c24f4dd4343bf6fa9abdb702aac0937953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1468-3083.2011.04131.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1468-3083.2011.04131.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21623928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karelson, M.</creatorcontrib><creatorcontrib>Silm, H.</creatorcontrib><creatorcontrib>Salum, T.</creatorcontrib><creatorcontrib>Kõks, S.</creatorcontrib><creatorcontrib>Kingo, K.</creatorcontrib><title>Differences between familial and sporadic cases of vitiligo</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><description>Background Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history.
Objective The aim of our study was to describe differences between familial and sporadic cases of vitiligo.
Methods A total of 186 adult vitiligo patients were examined, in 173 of whom the level of thyroid peroxidase antibodies, gastric parietal cell antibodies (PCA), antinuclear antibodies (ANA), anti‐adrenal cortex antibodies and rheumatoid factor in blood was measured. All patients were divided in two groups: the cases with positive family history of vitiligo (51) and the sporadic cases (135).
Results The risk of onset of the disease up to 20 years of age was higher in the familial group (P = 0.008). Patients in familial group showed more widespread depigmentation compared with sporadic cases [body surface area (BSA) over 10%: P = 0.004; BSA over 50%: P = 0.001]. In familial group, patients had darker skin phototype (P = 0.045) and the disease had started more often as a vulgar vitiligo (P = 0.008). In sporadic vitiligo group, female gender was a risk factor for more widespread depigmentation (BSA over 10%, P = 0.001). Extensive depigmentation was associated with reported triggering factors and mucosal involvement in both groups and with leukotrichia only in familial group. Widespread depigmentation related to the risk of presence of autoantibodies (P = 0.03) in sporadic cases of vitiligo (especially of PCA: P = 0.04 and ANA: P = 0.0002).
Conclusions In this study, we demonstrated first time that patients with familial vitiligo have a higher risk for vulgar type at the beginning of the disease and female gender increases the risk for more extensive depigmentation in sporadic cases.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Autoantibodies - analysis</subject><subject>Autoantibodies - immunology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Vitiligo - diagnosis</subject><subject>Vitiligo - genetics</subject><subject>Vitiligo - immunology</subject><subject>Young Adult</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMlOwzAQQC0EomX5BZQjlwRvWSzEAbEjKBJiu1mTeIxc0qbELbR_j0NLz_hiS_PeWHqERIwmLJyjYcJkVsSCFiLhlLGESiZYMt8g_fVgk_Sp4lmsVKp6ZMf7IaUBTYtt0uMs40Lxok-Oz5212OK4Qh-VOP1GHEcWRq52UEcwNpGfNC0YV0UV-MA0Nvpy0zB-b_bIloXa4_7q3iXPlxdPZ9fx3cPVzdnpXVxJmrMYgBrgWIAqMDOUZWmmgCmBqeGyFBWXVhojhRSlzSwoKE2ZUw5QUSVylYpdcrjcO2mbzxn6qR45X2FdwxibmdeMcs5TJVUR0GKJVm3jfYtWT1o3gnYRIN2l00PdFdJdId2l07_p9DyoB6tfZuUIzVr8axWAkyXw7Wpc_Huxvj1_6V7Bj5e-81Ocr31oP3SWizzVr4MrfU3vc_nGBvpR_ADXFIsx</recordid><startdate>201207</startdate><enddate>201207</enddate><creator>Karelson, M.</creator><creator>Silm, H.</creator><creator>Salum, T.</creator><creator>Kõks, S.</creator><creator>Kingo, K.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201207</creationdate><title>Differences between familial and sporadic cases of vitiligo</title><author>Karelson, M. ; Silm, H. ; Salum, T. ; Kõks, S. ; Kingo, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4071-aa0da2e8a98e6d016569a193e5d24b3c24f4dd4343bf6fa9abdb702aac0937953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Autoantibodies - analysis</topic><topic>Autoantibodies - immunology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Vitiligo - diagnosis</topic><topic>Vitiligo - genetics</topic><topic>Vitiligo - immunology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karelson, M.</creatorcontrib><creatorcontrib>Silm, H.</creatorcontrib><creatorcontrib>Salum, T.</creatorcontrib><creatorcontrib>Kõks, S.</creatorcontrib><creatorcontrib>Kingo, K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karelson, M.</au><au>Silm, H.</au><au>Salum, T.</au><au>Kõks, S.</au><au>Kingo, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences between familial and sporadic cases of vitiligo</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2012-07</date><risdate>2012</risdate><volume>26</volume><issue>7</issue><spage>915</spage><epage>918</epage><pages>915-918</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><abstract>Background Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history.
Objective The aim of our study was to describe differences between familial and sporadic cases of vitiligo.
Methods A total of 186 adult vitiligo patients were examined, in 173 of whom the level of thyroid peroxidase antibodies, gastric parietal cell antibodies (PCA), antinuclear antibodies (ANA), anti‐adrenal cortex antibodies and rheumatoid factor in blood was measured. All patients were divided in two groups: the cases with positive family history of vitiligo (51) and the sporadic cases (135).
Results The risk of onset of the disease up to 20 years of age was higher in the familial group (P = 0.008). Patients in familial group showed more widespread depigmentation compared with sporadic cases [body surface area (BSA) over 10%: P = 0.004; BSA over 50%: P = 0.001]. In familial group, patients had darker skin phototype (P = 0.045) and the disease had started more often as a vulgar vitiligo (P = 0.008). In sporadic vitiligo group, female gender was a risk factor for more widespread depigmentation (BSA over 10%, P = 0.001). Extensive depigmentation was associated with reported triggering factors and mucosal involvement in both groups and with leukotrichia only in familial group. Widespread depigmentation related to the risk of presence of autoantibodies (P = 0.03) in sporadic cases of vitiligo (especially of PCA: P = 0.04 and ANA: P = 0.0002).
Conclusions In this study, we demonstrated first time that patients with familial vitiligo have a higher risk for vulgar type at the beginning of the disease and female gender increases the risk for more extensive depigmentation in sporadic cases.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21623928</pmid><doi>10.1111/j.1468-3083.2011.04131.x</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0926-9959 |
ispartof | Journal of the European Academy of Dermatology and Venereology, 2012-07, Vol.26 (7), p.915-918 |
issn | 0926-9959 1468-3083 |
language | eng |
recordid | cdi_proquest_miscellaneous_1022259498 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Adolescent Adult Aged Autoantibodies - analysis Autoantibodies - immunology Child Child, Preschool Humans Middle Aged Vitiligo - diagnosis Vitiligo - genetics Vitiligo - immunology Young Adult |
title | Differences between familial and sporadic cases of vitiligo |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A16%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20between%20familial%20and%20sporadic%20cases%20of%20vitiligo&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Karelson,%20M.&rft.date=2012-07&rft.volume=26&rft.issue=7&rft.spage=915&rft.epage=918&rft.pages=915-918&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/j.1468-3083.2011.04131.x&rft_dat=%3Cproquest_cross%3E1022259498%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1022259498&rft_id=info:pmid/21623928&rfr_iscdi=true |